Cancer-fighting T cells need small amounts of ROS to attack tumors, study finds

How tumors silence T cells 

Considering future therapies 

Eil said his team and collaborators will continue studying how tumors suppress immune responses and how those mechanisms can be overcome through next-generation immunotherapies, including engineered T cell therapies.

Source:

Oregon Health & Science University

Journal reference: